Radiation Therapy in Cancer: Current Approaches, Challenges, And Future Directions

Modern oncology still relies heavily on radiation therapy (RT), which is an essential part of multimodal cancer treatment plans that also include immunotherapy, chemotherapy, surgery, and targeted medicines. Through the use of high-energy ionizing radiation, RT prevents tumor growth while attempting to protect nearby normal tissues by causing deadly DNA damage in cancerous cells through both direct ionization and indirect free radical production. Rapid technical advancements over the past few decades, including proton and heavy ion therapy, intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), and stereotactic procedures, have significantly improved the safety, accuracy, and conformance of treatment administration. Beyond these technical innovations, deeper insights into tumor biology, radiogenomics, and the tumor microenvironment have enabled more personalized approaches and synergistic combinations with immunotherapy, chemotherapy, and radiosensitizers. RT is now applied across a broad spectrum of cancers, including breast, lung, prostate, head and neck, gynecologic, and central nervous system tumors, where it plays a critical role in local control, organ preservation, and improved survival. Despite these advances, challenges persist, such as treatment-related acute and late toxicities, tumor hypoxia, and radioresistance, which limit efficacy in certain patient populations. Looking forward, integration of adaptive RT, artificial intelligence, nanotechnology, and molecular biomarkers promises to transform radiation oncology into a more precise, personalized, and effective discipline. This review provides a comprehensive overview of the principles, modalities, clinical applications, challenges, and emerging directions of radiation therapy in the management of cancer.